Search

Author/Creator Petrylak, Daniel P.

1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts: National Harbor, MD, USA. 9-13 November 2016. (8th December 2016)

Authors:
Althammer, Sonja; Steele, Keith; Rebelatto, Marlon; Tan, Tze Heng; Wiestler, Tobias; Schmidt, Guenter; Higgs, Brandon; Li, Xia; Shi, Li; Jin, Xiaoping; Antal, Joyce; Gupta, Ashok; Ranade, Koustubh; Binning, Gerd; Bellmunt, Joaquim; de Wit, Ronald; Vaughn, David J.; Fradet, Yves; Lee, Jae Lyun; Fo...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 4(2016)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016)

Authors:
Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina C.; Bajaj, Anshika; Archer, Jacob F.; Reeves, Rebecca S.; Ngo, Lisa Y.; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fu...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 4(2016)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. An open‐label, single‐arm, phase 2 trial of the polo‐like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancer. Issue 7 (11th December 2013)

Authors:
Stadler, Walter M.; Vaughn, David J.; Sonpavde, Guru; Vogelzang, Nicholas J.; Tagawa, Scott T.; Petrylak, Daniel P.; Rosen, Peter; Lin, Chia‐Chi; Mahoney, John; Modi, Sanjiv; Lee, Peter; Ernstoff, Marc S.; Su, Wu‐Chou; Spira, Alexander; Pilz, Korinna; Vinisko, Richard; Schloss, Charles; Fritsch, ...
Journal:
Cancer
Issue:
Volume 120:Issue 7(2014)
Page Start:
976
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. An open‐label, single‐arm, phase 2 trial of the polo‐like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancer. Issue 7 (11th December 2013)

Authors:
Stadler, Walter M.; Vaughn, David J.; Sonpavde, Guru; Vogelzang, Nicholas J.; Tagawa, Scott T.; Petrylak, Daniel P.; Rosen, Peter; Lin, Chia‐Chi; Mahoney, John; Modi, Sanjiv; Lee, Peter; Ernstoff, Marc S.; Su, Wu‐Chou; Spira, Alexander; Pilz, Korinna; Vinisko, Richard; Schloss, Charles; Fritsch, ...
Journal:
Cancer
Issue:
Volume 120:Issue 7(2014)
Page Start:
976
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Cabozantinib plus docetaxel and prednisone in metastatic castration‐resistant prostate cancer. (23rd October 2020)

Authors:
Madan, Ravi A.; Karzai, Fatima H.; Al Harthy, Munjid; Petrylak, Daniel P.; Kim, Joseph W.; Arlen, Philip M.; Rosner, Inger; Theoret, Marc R.; Cordes, Lisa; Bilusic, Marijo; Peer, Cody J.; Dawson, Nancy A.; Couvillon, Anna; Hankin, Amy; Williams, Moniquea; Chun, Guin; Owens, Helen; Marte, Jennifer...
Journal:
BJU international
Issue:
Volume 127:Number 4(2021)
Page Start:
435
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Double‐blind, randomized, phase 2 trial of maintenance sunitinib versus placebo after response to chemotherapy in patients with advanced urothelial carcinoma. Issue 5 (18th November 2013)

Authors:
Grivas, Petros D.; Daignault, Stephanie; Tagawa, Scott T.; Nanus, David M.; Stadler, Walter M.; Dreicer, Robert; Kohli, Manish; Petrylak, Daniel P.; Vaughn, David J.; Bylow, Kathryn A.; Wong, Steven G.; Sottnik, Joseph L.; Keller, Evan T.; Al‐Hawary, Mahmoud; Smith, David C.; Hussain, Maha
Journal:
Cancer
Issue:
Volume 120:Issue 5(2014)
Page Start:
692
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗